Thase MF, Fava M, Hollander S, Simmons JH, Ivgy-May N, Boyle K, Gibertini M. Analysis of the effects of gepirone-ER on the Bech-6 and individual HAM-D 17-item scores. Poster presented at the 2003 42nd ACNP Annual Meeting; December 2003. San Juan, Puerto Rico.
Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.
Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.
Estrada CA, Unterborn JN, Price J, Thompson D, Gibson L. Judging the effectiveness of clinical pathways for pneumonia: the role of risk adjustment. Eff Clin Pract. 2000 Sep 1;3(5):221-8.
Price MA. Standard-setting report for the compliance official qualification examination (series 14). 2000.
Cichy E, Price MA, Warren E. Job analysis report for the general securities sales supervisor qualification examination (series 8). 2000.
Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Hypertension management in long-term care: opportunities for quality improvement. Poster presented at the American Medical Directors Association; 2000. San Francisco, CA.
Sacco P, Katz J, Ulanday N. Treatment of skilled nursing facility residents with Resurfix. Poster presented at the American Society of Consultant Pharmacists; January 2000. Chicago, IL.